Legence
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 2 weeks.
- Recent price momentum is -33.7% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has fallen to 3.3% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 08:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation C+
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 55.2x | Better than 8% |
| Forward P/E | 10.0x | Better than 80% |
| Price / Sales | 0.6x | Better than 88% |
| P/E vs own 5-yr range | 100th pctl | Better than 1% |
Growth A+
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 27.0% | Better than 88% |
| Free cash flow CAGR (3Y) | 584.0% | Better than 100% |
Profitability D+
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 21.0% | Better than 19% |
| Operating margin | 3.6% | Better than 30% |
| Net margin | -2.3% | Better than 22% |
| Return on equity | -13.2% | Better than 18% |
| Return on invested capital | 0.7% | Better than 30% |
Momentum D-
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -45.6% | Better than 7% |
| 6-month return | -60.4% | Better than 4% |
| 12-month return (ex latest month) | -11.5% | Better than 21% |
| Distance below 52-week high | 69.9% | Better than 6% |
Financial Health D+
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 1.6x | Better than 43% |
| Debt to assets | 43.4% | Better than 22% |
| Interest coverage | 0.5x | Better than 26% |
| Free cash flow / net income | 105.6% | Better than 42% |
Analyst View A
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 88.9% | Better than 72% |
| Upside to average target | 160.7% | Better than 91% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 35.09
- Open
- 33.51
- Day range
- 31.76 - 34.99
- Avg price
- 32.50
- Volume
- 1.49M
- Turnover
- 48.28M
- Turnover ratei
- 2.57%
- Volume ratioi
- 1.04
- Amplitudei
- 9.21%
- 52-week rangei
- 23.90 - 107.24
Valuation
- P/Ei
- -34.52
- P/E (TTM)i
- 55.23
- P/Bi
- 3.66
- EPSi
- -0.94
- Book value / shi
- 8.82
- Net profit
- -72.41M
- Net assets
- 682.52M
Share structure
- Market cap
- 2.50B
- Float capi
- 1.87B
- Shares out
- 77.36M
- Float sharesi
- 57.79M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2025-09-12
69.9% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-16.00M net over the window
Short interest
- Shares short
- 2.56M
- % of floati
- 3.33%
- Days to coveri
- 1.53
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Legence (LGN)?
Legence last traded at 32.31. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Legence's market cap?
About 2.50B.
What is the P/E ratio of Legence?
The trailing twelve-month P/E is 55.23. The Valuation tab shows it against the stock's own five-year range.
Does Legence pay a dividend?
Legence does not currently pay a regular dividend.
Is Legence a buy according to analysts?
The consensus of 9 analysts is a Buy rating, with an average 12-month price target of 84.22, which implies 160.7% upside from the current price. This is not investment advice.
What is Legence's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Legence a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Legence discussion 0 comments